drugset / Trial / NCT03610945

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

NCT03610945

Phase 1 Completed 48 enrolled Enanta Pharmaceuticals, Inc
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This is a non-randomized, 2-part, open-label, drug-drug interaction (DDI) study to evaluate the effect of concomitant administration of fluconazole or quinidine on the pharmacokinetics and safety of EDP-305 in healthy human volunteers.

Timeline

Start
2018-07-19
Primary completion
2018-08-15
Completion
2018-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject EDP-305 Unknown
Subject Fluconazole Small molecule
Subject Quinidine Small molecule